Company profile: Marvel Biotechnology
1.1 - Company Overview
Company description
- Provider of biotech discovery and development of synthetic derivatives of proven drugs, including MB-204, a fluorinated derivative of istradefylline, for neurological diseases (depression, anxiety, Alzheimer's, ADHD), liver fibrosis due to NASH, and adjunctive cancer therapies.
Products and services
- MB-204: Custom-engineered fluorinated derivative of Istradefylline being developed for depression, Alzheimer’s disease, liver fibrosis due to NASH, and other neurological and non-neurological conditions
- Non-Alcoholic Steatohepatitis (NASH): Hepatology-focused development of treatments addressing liver fibrosis caused by NASH, targeting an area with no currently approved therapies for this progressive condition
- Neurological Diseases: Indication-specific therapeutics targeting depression, anxiety, Alzheimer’s, and ADHD that have not been effectively treated by conventional therapeutics
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Marvel Biotechnology
PharmaSeek
HQ: United States
Website
- Description: Provider of consulting and training solutions for clinical research sites, helping institutions, investigators, and independent sites decrease study start-up timelines by assuming administrative burdens of research management, including study identification, contract and budget negotiation, coverage analysis, and financial management.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full PharmaSeek company profile →
Irisys
HQ: United States
Website
- Description: Provider of contract pharmaceutical product development and manufacturing services, offering pharmaceutical research and development and formulation development.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Irisys company profile →
Syner-G BioPharma
HQ: United States
Website
- Description: Provider of pharmaceutical development and CMC solutions; cGMP and quality/compliance services; regulatory strategy and submissions spanning CMC, nonclinical, and clinical; functional outsourcing partnerships with dedicated regulatory staff; medical writing for scientifically accurate, compliant documents; and CMC consulting focused on strategy, compliance, and process optimization in drug development.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Syner-G BioPharma company profile →
OcellO
HQ: The Netherlands
Website
- Description: Provider of CRO services for the drug discovery industry, developing clinically relevant in vitro human micro-tissue models for screening and profiling of small molecules and biologics to improve the efficiency of lead development.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full OcellO company profile →
Adare Pharma Solutions
HQ: United States
Website
- Description: Provider of global technology-driven CDMO services spanning research, business and product development, formulation development (taste masking, customized release, patient-centered dosage forms), analytical services, clinical trial materials manufacturing and packaging (GMP and Non-GMP), commercial manufacturing, packaging, and logistical support, with delivery technologies including Diffucaps®, Microcaps®, and Optimμm®.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Adare Pharma Solutions company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Marvel Biotechnology
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Marvel Biotechnology
2.2 - Growth funds investing in similar companies to Marvel Biotechnology
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Marvel Biotechnology
4.2 - Public trading comparable groups for Marvel Biotechnology
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →